Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Chemotherapy Exposed Breast Cancer Survivors
NCT02822573Phase 3Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in chemotherapy-induced cognitive impairment (CICI), sponsored by Wake Forest University Health Sciences. Started May 2017; status: completed.
02
Drugs
donepezil
03
Conditions
chemotherapy-induced cognitive impairment (CICI)
Beyond the preview
Go deeper on NCT02822573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822573.